News | July 17, 2024
Lupin divests US commercial women's health specialty business to Evofem
Lupin can receive a potential total consideration of up to USD 84 million based on future contingent milestones
Lupin can receive a potential total consideration of up to USD 84 million based on future contingent milestones
The inspection closed with five observations which were more of procedural changes with none of these related to data integrity
ProtocolCopilot leverages advanced artificial intelligence to streamline the process of understanding and adhering to clinical research protocols
Shoff brings over 30 years of international experience in in vitro diagnostics, healthcare distribution and veterinary diagnostics
_256_384.jpg)
€ 6.6 million investment at Nantong site expands production capabilities for cell culture media
Acquisition strengthens and diversifies Merck’s pipeline with the addition of Restoret
Findings from the SEIMC-GeSIDA Foundation (FSG) PASO-DOBLE study will include treatment efficacy, safety, and weight gain
Enhanced collaboration under the Memorandum of Cooperation (MoC) between India and Japan in medical product regulations
The company will address these observations within the stipulated timeline
Selexipag is a prostacyclin receptor agonist indicated for the treatment of pulmonary arterial hypertension
Subscribe To Our Newsletter & Stay Updated
